Illumina Inc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ILU.MU | ALINT.PA | GNTA | ILLM.TO | INV | 048530.KQ | |
|---|---|---|---|---|---|---|
| Market cap | — | 496.55K | 47.49M | 34.11M | 18.75M | 82.17B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | — | -1.5 | -32.5 | -0.4 | — |
| Price/book | — | -0.5 | 0.9 | 0.5 | 0.1 | — |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +104.37% | −47.37% | −69.43% | −42.73% | −93.55% | −17.92% |
| Today | −4.34% | 0.00% | +18.82% | +3.17% | −16.11% | −2.39% |
The closest companies by business. Prices may be delayed up to 20 min.
Latest news
All ILU.MU news ›[PRNewswire] Illumina selected to provide services for SG-INSIGHT
Yonhap News Agency SINGAPOR, Nov. 5, 2026 /PRNewswire=YONHAP/ -- Illumina, Inc. (Nasdaq: ILMN) announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore'
Why Did Illumina Stock Jump?
Illumina (ILMN) stock rose 5.1% on Tuesday, November 3, 2026, alongside a 0.4% advance for the S&P 500. The move followed a November 2 announcement that the company was selected to provide whole-genome sequencing services for a national…
Illumina partners with Singapore for whole genome sequencing research initiative
Vietnam Investment Review - VIR Illumina partners with Singapore for whole genome sequencing research initiative SINGAPORE â Media OutReach Newswire â 3 November 2026 â Illumina, Inc. (Nasdaq: ILMN) today announc
Illumina, Inc. Stock 12‑Month Price Target Cut to $264.84, Implies 11% Upside
TradingView Illumina, Inc. Stock 12‑Month Price Target Cut to $264.84, Implies 11% Upside - According to estimates from 19 analysts, Illumina, Inc. stock's average price target has fallen from $267.47 to $264.84, with for
Illumina, Inc. (ILMN) Selected For Study Covering Around 450,000 Singapore Residents
TradingView Illumina, Inc. (ILMN) Selected For Study Covering Around 450,000 Singapore Residents Illumina was selected to provide whole-genome sequencing for Singapore's SG-INSIGHT study, expected to include approx
Illumina selected to help bring precision medicine into everyday healthcare in Singapore
News-Press NOW SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singaporeâs healthcare s
Analysts’ Recent Ratings Updates for Illumina (ILMN)
Posted by Tristan Rich on Nov 4th, 2026 A number of research firms have changed their ratings and price targets for Illumina (NASDAQ: ILMN): The company’s offerings include next-generation sequencing systems, consumable flow cells and…
Illumina, Inc. (NASDAQ:ILMN) Stock Has Consensus Target Price of $238.53
Posted by Danessa Lincoln on Nov 4th, 2026 View Our Latest Stock Analysis on ILMN Here are the key news stories impacting Illumina this week: The company’s offerings include next-generation sequencing systems, consumable flow cells and…
Illumina Inc Selected To Provide Whole-Genome Sequencing Services For SG-INSIGHT Study In Singapore
marketscreener.com had been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine programme The study is e
Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal - Law360
Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal Law360 is on it, so you are,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com22
- tradingview.com9
- seekingalpha.com6
- themarketsdaily.com6
- stocktitan.net5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 96 articles, not a forecast.